Page last updated: 2024-10-28

hydralazine and Abortion, Spontaneous

hydralazine has been researched along with Abortion, Spontaneous in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Abortion, Spontaneous: Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference.

Research Excerpts

ExcerptRelevanceReference
"Hydralazine was administered in daily doses of 50 mg, starting 24-36 h after the initial diagnosis of EUVI and continuing throughout the first trimester."1.72First-trimester miscarriage rate decreases with hydralazine therapy in pregnancies with early uterine vascular insufficiency: a cohort study. ( Biron, M; Canals, A; Castiglione, A; Faundez, R; Leible, S; Mitelman, G; Sepulveda, W; Walton, R, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Leible, S1
Canals, A1
Walton, R1
Mitelman, G1
Castiglione, A1
Biron, M1
Faundez, R1
Sepulveda, W1

Other Studies

1 other study available for hydralazine and Abortion, Spontaneous

ArticleYear
First-trimester miscarriage rate decreases with hydralazine therapy in pregnancies with early uterine vascular insufficiency: a cohort study.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2022, Volume: 35, Issue:25

    Topics: Abortion, Spontaneous; Cohort Studies; Female; Humans; Hydralazine; Pregnancy; Pregnancy Trimester,

2022